Eli Lilly and Company (LLY)
NYSE·Healthcare·Drug Manufacturers - General
$1,120.60
-0.83%
Mkt Cap $1.07T
Analyst Ratings
Buy
17
Hold
1
Sell
0
Price Target (106 analysts)
$1,243.95
Range $985.00 – $1,350.00
Implied Upside
+11.0%
Consensus $1,243.95 vs current $1,120.60